Table 1.
Characteristics of the included patients in miRNA microarray analysis.
| Variables | Patients (%) | Values Mean ± SD | |
|---|---|---|---|
| Age, years | 35 (100.0) | 53.6 ± 8.8 | |
| Gender | Male | 26 (74.3) | |
| Female | 9 (25.7) | ||
| Etiology of cirrhosis | |||
| Hepatitis C | Male | 10 (28.6) | |
| Female | 4 (11.4) | ||
| Hepatitis B | Male | 2 (5.7) | |
| Female | 1 (2.9) | ||
| Alcohol | Male | 21 (60.0) | |
| Female | 1 (2.9) | ||
| ACLF | 20 (57.1) | ||
| Bacterial infection (first 48 h) | 16 (45.7) | ||
| Ascites at admission | 21 (60.0) | ||
| Medications at admission | |||
| Propranolol | 15 (42.9) | ||
| Spironolactone | 15 (42.9) | ||
| Furosemide | 12 (34.3) | ||
| Lactulose | 10 (28.6) | ||
| Omeprazole | 14 (40.0) | ||
| Oral hypoglycemic* | 4 (11.4) | ||
| Insulin | 3 (8.6) | ||
| Death in 30 days | 7 (20.0) | ||
| Biochemical data | |||
| Total bilirubin (mg/dL) | 35 (100.0) | 4.9 ± 7.9 | |
| INR | 33 (94.3) | 1.5 ± 0.3 | |
| CRP (mg/L) | 28 (80.0) | 35.0 ± 45.8 | |
| Creatinine (mg/dL) | 26 (74.3) | 1.5 ± 0.8 | |
| Albumin (g/dL) | 34 (97.1) | 2.4 ± 0.5 | |
| Sodium (mEq/L) | 33 (94.3) | 134.4 ± 4.9 | |
| Total leukocyte (mm3) | 32 (91.4) | 7163.8 ± 5923.0 | |
ACLF. acute-on-chronic liver failure; SD. standard deviation; INR. international normalized ratio; CRP. C-reactive protein. *Metformin, glibenclamide and glimepiride.